These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38604404)

  • 81. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.
    Leving MT; Bosnic-Anticevich S; van Cooten J; de Sousa JC; Cvetkovski B; Dekhuijzen R; Dijk L; Pardo MG; Gardev A; Gawlik R; van der Ham I; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price D; Roman-Rodriguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani O; Emerson-Stadler R; Kocks JWH
    NPJ Prim Care Respir Med; 2022 Dec; 32(1):59. PubMed ID: 36575175
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
    Riley JH; Tabberer M; Richard N; Donald A; Church A; Harris SS
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1873-80. PubMed ID: 27578968
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Influences of gender and anthropometric features on inspiratory inhaler acoustics and peak inspiratory flow rate.
    Taylor TE; Holmes MS; Sulaiman I; Costello RW; Reilly RB
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2227-30. PubMed ID: 26736734
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
    Zhang W; Xu L; Gao S; Ding N; Shu P; Wang Z; Li Y
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1471-1479. PubMed ID: 32606655
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.
    Mahler DA; Watz H; Emerson-Stadler R; Ritz J; Gardev A; Shaikh A; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1729-1740. PubMed ID: 37599896
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD.
    Mahler DA; Halpin DMG
    Chest; 2021 Aug; 160(2):491-498. PubMed ID: 33812852
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study.
    Singh D; Ciurlia G; Piccinno A; Muraro A; Bocchi M; Scuri M
    Pulm Pharmacol Ther; 2017 Feb; 42():43-51. PubMed ID: 28065679
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
    Yildiz P; Bayraktaroglu M; Gorgun D; Yuksel K
    Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ability of using different dry powder inhalers during COPD exacerbations.
    Papaioannou AI; Herodotou Y; Tomos I; Apollonatou V; Verykokou G; Papathanasiou E; Manali ED; Loukides S; Papiris SA
    Pulm Pharmacol Ther; 2018 Feb; 48():211-216. PubMed ID: 29277688
    [TBL] [Abstract][Full Text] [Related]  

  • 95. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD.
    Vartiainen VA; Lavorini F; Murphy AC; Rabe KF
    Expert Opin Drug Deliv; 2023 Mar; 20(3):385-393. PubMed ID: 36820500
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates.
    Clark AR; Weers JG; Dhand R
    J Aerosol Med Pulm Drug Deliv; 2020 Feb; 33(1):1-11. PubMed ID: 31613682
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices.
    Ram FS; Carvallho CR; White J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():129-39. PubMed ID: 21468167
    [TBL] [Abstract][Full Text] [Related]  

  • 98. FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy.
    González-Torralba F; Baloira A; Abad A; Fuster A; García-Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1005-1015. PubMed ID: 35547784
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    Shepherd T; Kennett M; Cooper A; Parkinson A
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):154-165. PubMed ID: 34726509
    [No Abstract]   [Full Text] [Related]  

  • 100. Accuracy of inhaler use in patients with chronic obstructive pulmonary disease.
    Lee H; Boo S; Lim Y; Kim S; Kim IA
    Clin Nurs Res; 2014 Oct; 23(5):560-74. PubMed ID: 23922162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.